Performance of vitek 2 for antimicrobial susceptibility testing of acinetobacter baumannii, pseudomonas aeruginosa, and stenotrophomonas maltophilia with vitek 2 (2009 FDA) and CLSI M100S 26th edition breakpoints

April M. Bobenchik, Eszter Deak, Janet A. Hindler, Carmen L. Charlton, Romney M. Humphries

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Performance of vitek 2 for antimicrobial susceptibility testing of acinetobacter baumannii, pseudomonas aeruginosa, and stenotrophomonas maltophilia with vitek 2 (2009 FDA) and CLSI M100S 26th edition breakpoints'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology